Company Performance Metrics
- Alain Woodtli: QA/RA Director
- Antoine Barraud: CEO & Co-Founder
AMF Medical is using proprietary breakthrough technologies and world-class user-experience design to develop Sigi, a novel patch pump to administer insulin, with unparalleled ease of use and ready for seamless integration into closed loop systems, with 3rd party Continuous Glucose Monitoring products and dose-calculating algorithms. The vision is
to reduce therapy “burden” and offer a simple, better life for people with diabetes. In early 2021, AMF Medical SA was separated from Advanced Microfluidics SA, which – using related technologies - develops, manufactures, and commercializes high-end lab equipment components.